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Abstract
Objective: To investigate whether (1) maternal psychosocial stress (depression/anxiety) during pregnancy is associated
with offspring vascular function and (2) whether any association differs depending on the gestational timing of exposure
to stress. We also investigated whether any association is likely to be due to intrauterine mechanisms by (3) comparing
with the association of paternal stress with offspring vascular function and (4) examining whether any prenatal associ-
ation is explained by maternal postnatal stress.
Methods and results: Associations were examined in a UK birth cohort, with offspring outcomes (systolic and
diastolic blood pressure, SBP and DBP, endothelial function assessed by brachial artery flow-mediated dilatation
(FMD); arterial stiffness assessed by carotid to radial pulse wave velocity (PWV), brachial artery distensibility (DC),
and brachial artery diameter (BD) assessed at age 10–11 years (n¼4318). Maternal depressive symptoms and anxiety
were assessed at 18 and 32 weeks gestation and 8 months postnatally. Paternal symptoms were assessed at week 19.
With the exception of DBP and BD, there were no associations of maternal depressive symptoms with any of the
vascular outcomes. Maternal depressive and anxiety symptoms were associated with lower offspring DBP and wider BD,
though the latter attenuated to the null with adjustment for confounding factors. Paternal symptoms were not associated
with offspring outcomes. Maternal postnatal depressive symptoms were associated with lower offspring SBP.
Conclusions: We found no evidence to support the hypothesis that maternal stress during pregnancy adversely affects
offspring vascular function at age 10–12 years via intrauterine mechanisms.
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Introduction
Maternal stress or the administration of glucocorticoids
(‘stress hormones’) have been linked to altered fetal
growth and might have permanent eﬀects on the
tissue structure and function of the oﬀspring.
1 For
example, the hypothalamic–pituitary–adrenal axis,
which is a key part of the neuroendocrine stress
response, and the renin–angiotensin system may be
aﬀected by intrauterine exposure to maternal stress,
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cular disease.
2–17
Convincing evidence for the eﬀects of fetal program-
ming on cardiovascular risk factors comes from animal
studies, in which prenatal exposure to excess gluco-
corticoids results in persistent elevation of arterial
blood pressure (BP) in adulthood, with potential sex
diﬀerences (for review, see Drake et al.
18). There is
also some evidence from human studies. For example,
antenatal glucocorticoid administration is linked with
high BP in the fetus
19 and in adolescence.
20 Those stu-
dies have, however, been complicated by high doses of
glucocorticoids, which are not comparable to levels
normally occurring during pregnancy. In addition,
glucocorticoid treatment usually takes place when
pre-term birth is expected, adding bias because of the
complications of premature birth. Few pregnant
women will be treated with glucocorticoids, but the
results of these studies have been used to suggest that
common mental complaints (depression and anxiety)
associated with stress, if experienced by the mother
during pregnancy might increase her oﬀspring’s risk
of cardiovascular disease. If this is true it would have
important public health implications, but to our know-
ledge few studies have examined this.
In a previous study in a Dutch population-based
birth cohort (ABCD study), the presence of multiple
psychosocial stressors during early pregnancy was asso-
ciated with higher BP in the oﬀspring at age ﬁve.
21
However, we are unaware of any other human studies
of this association and this needs further replication
and additional exploration to see if any association is
likely to reﬂect a causal intrauterine mechanism.
The aim of this study was to examine whether (1)
maternal psychosocial stress (depression/anxiety)
during pregnancy is associated with oﬀspring vascular
function (assessed by systolic blood pressure (SBP),
diastolic blood pressure (DBP), endothelial function
assessed by brachial artery ﬂow-mediated dilatation
(FMD), arterial stiﬀness assessed by carotid to radial
pulse wave velocity (PWV), brachial distensibility coef-
ﬁcient (DC), and brachial artery diameter) and (2)
whether any association diﬀers depending on the gesta-
tional timing of exposure to stress. We further exam-
ined whether there is evidence that any association of
maternal stress with oﬀspring vascular function is likely
to be due to intrauterine mechanisms by comparing the
associations of maternal stress with oﬀspring outcomes
to those of paternal antenatal stress with the same out-
comes and by examining whether any maternal pre-
natal association was explained by the persistence of
symptoms into the postnatal period and exposure post-
natally (rather than intrauterine driving associations).
The paternal comparison is an important form of nega-
tive control for exploring a causal association in
observational epidemiology.
22,23 The rationale is that
if maternal stress is truly causing oﬀspring outcomes
via intrauterine mechanisms (as opposed to family
based confounding) then one would expect a stronger
maternal association, compared to paternal associ-
ation. Examining whether any maternal pregnancy
stress association with oﬀspring outcomes is largely
mediated by postnatal stress is also important as if
the eﬀect is largely due to postnatal impact then any
intervention to prevent adverse oﬀspring outcomes
would want to focus on minimizing postnatal stress.
Methods
Study population
Data from the Avon Longitudinal Study of Parents and
Children (ALSPAC), a prospective population-based
birth cohort that recruited 14,541 pregnant women resi-
dent in Avon, UK with expected dates of delivery 1
April 1991 to 31 December 1992 were used.
Additional details of the study can be found on the
study website (www.alspac.bris.ac.uk) and in previous
publications.
24–26 Figure 1 shows the ﬂow of partici-
pants through the study. In this study, we included
mother–oﬀspring pairs where there was a singleton
pregnancy resulting in a live birth with the child surviv-
ing to at least 1 year of age. The eligible cohort for the
current analyses was the 4318 mother–oﬀspring pairs
who had complete data on maternal depressive symp-
toms and anxiety at both gestational time points, oﬀ-
spring blood pressure (obtained at the 10–11-year
follow-up clinic), and complete data on all covariates.
Parental assessment of psychosocial stress
Data on depressive symptoms and anxiety were col-
lected through postal questionnaires, which the
mothers in the current sample ﬁlled out at a median
gestational age of 18 weeks (mean 19; interquartile
range 18–20) and median 32 weeks (mean 32; interquar-
tile range 32–33) antenatally and median 8 months
postnatally (mean 8.6; interquartile range 8.1–9.1).
Fathers completed one questionnaire at a median 19
weeks of their partners’ pregnancy (mean 20; interquar-
tile range 19–21). Maternal and paternal depressive
symptoms at all time points were assessed using the
Edinburgh Postnatal Depression Scale (EPDS), a
widely used 10-item self-report questionnaire that has
been shown to be valid in and outside the postnatal
period.
27 A pilot study of a random sample of 54 preg-
nant women attending a routine check-up indicated
substantial overlap between the EPDS and the Center
for Epidemiological Studies Depression Scale
(r
2¼0.87, p<0.001). Internal consistency (Cronbach’s
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assessments.
28
Maternal and paternal anxiety at all time points was
measured using the anxiety items from the Crown–
Crisp experiential index (CCEI), a validated self-
rating inventory (for example, see Crisp et al.
29); exam-
ple items include ‘worry a lot’ and ‘feeling strung up
inside’). In a pilot study of a random sample of 54
pregnant women attending a routine check-up,
Crown–Crisp index correlated 0.70 and 0.76 with the
State and Trait (respectively) subscales of the
Spielberger State-trait Anxiety Inventory. Internal con-
sistency (Cronbach’s alpha) exceeded 0.80 at each of
the assessments.
28
To compare prenatal and postnatal maternal stress
we categorized all EPDS and CCEI scores into ‘high
levels of anxiety/depressive symptoms’ (yes versus no)
by dichotomizing at the 80th percentile (those classiﬁed
as having ‘high levels’ included those with values at or
higher than the 80th percentile; those classiﬁed as
‘normal’ included those with values lower than the
80th percentile). We then further categorized partici-
pants into those with normal levels at all time points;
prenatal high levels only; postnatal high levels only, or
pre- and postnatal high levels.
Vascular function in the child
Vascular phenotypes were assessed at the 10–11-year
follow-up assessment and detailed descriptions of the
measurements have been previously reported.
30,31
Blood pressure was measured with the automatic
14,541 pregnant women
recruited
14,273 singleton
pregnancies
13,617 live born offspring
who survived to at least
age 1 year
5619 completed vascular
assessment at age 10-11
595 pregnancy loss
61 died in first year
69 lost to follow-up
199 multiple pregnancy
1301 missing
covariable data
11,433 invited to
assessment at age 10-11;
6919 attended
N=4318
included in main analyses
with blood pressure
N=3421
prenatal & postnatal
depressive symptoms
N=3589
paternal
depressive symptoms
N=3576
paternal anxiety
N=3375
prenatal & postnatal
anxiety
Figure 1. Participant flow.
Data in the yellow boxes are for mother(father)–child pairs with complete data.
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forms were recorded transcutaneously using a high-
ﬁdelity micromanometer (SPC-301; Millar
Instruments, Houston, TX, USA) from the radial and
carotid pulse, synchronous with the ECG signal.
Integral software processed the data to calculate the
mean time diﬀerence between R-wave and pressure
wave on a beat-to-beat basis over 10s, and the PWV
was then calculated using the mean time diﬀerence and
arterial path length between the two recording points
(SphygmoCorversion 7.1; Scanmed, UK). Ultrasound
images of the right brachial artery were used to measure
FMD and DC. Images were recorded onto SVHS video
using an ALOKA 5500 high-resolution ultrasound
system with a 5–10MHz linear array probe (Keymed,
UK) and the measurements were undertaken later from
the videos at the Vascular Physiology Unit, Institute of
Child Health, London. The right brachial artery was
imaged 5–10cm above the antecubital fossa. FMD
was induced by a 5-min inﬂation of a pneumatic cuﬀ,
placed around the forearm immediately below the
medial epicondyle, to 200mmHg followed by rapid
deﬂation using an automatic air regulator. The diam-
eter of the brachial artery was measured using edge
detection software (Brachial Tools, MIA, IA, USA)
from ECG-triggered ultrasound images captured at
3s intervals throughout the 11-min recording protocol.
FMD was expressed as an absolute value in our ana-
lyses.
31 The distension of the artery was determined by
measuring the luminal diameter excursion from diastole
to systole. Distensibility coeﬃcient was calculated from
the distension and the pulse pressure and was expressed
as mean per cent change in cross-sectional area per unit
change in blood pressure.
Covariates
Maternal age, gestational age, birthweight, and oﬀ-
spring sex were obtained from obstetric records. Self-
reported weight and height at the time of recruitment
were used to calculate maternal pre-pregnancy body
mass index (BMI; Pearson’s correlation with measured
weight at ﬁrst antenatal clinic r
2¼0.95, p<0.0001).
Parity was obtained from a maternal completed ques-
tionnaire at 18 weeks gestation and for these analyses
we dichotomized this (any previous pregnancies yes/
no). Based on questionnaire responses, the highest par-
ental occupation was used to allocate the children to
head of household occupational social class groups
(classes I (professional/managerial) to V (unskilled
manual workers), using the 1991 British Oﬃce of
Population and Census Statistics classiﬁcation).
Ethnicity was based on the mothers’ self-report
(White; Black Caribbean; Black African; Other Black;
Indian; Pakistani; Bangladeshi; Chinese; Other).
Mothers were repeatedly asked about their smoking
throughout pregnancy and these data were used to gen-
erate a categorical variable (never smoked; smoked
before pregnancy or in the ﬁrst trimester and then
stopped; smoked throughout pregnancy). A categorical
variable on alcohol consumption was deﬁned based on
a question in the questionnaire at gestational week 18
(no drinking; less than 1 glass per week; more than 1
glass per week; more than 1 glass per day).
Age of the child at the time of vascular function
assessment was recorded in months as they arrived at
the assessment clinics. Weight was measured to the
nearest 0.1kg using Tanita scales. Height was measured
to the nearest 0.1cm using a Harpenden stadiometer.
Statistics
Associations between the stress measures (at all time
points) and oﬀspring vascular outcome measures were
explored using multivariable linear regression with the
statistical package SPSS version 18.0 (SPSS, Chicago,
USA). In model 1 we adjusted for sex, height, and age
of the child at the time of vascular assessment. In model
2 we additionally adjusted for maternal confounders
(age, ethnicity, pre-pregnancy BMI, nulliparity, social
class, smoking, and alcohol consumption). In model 3
we adjusted for potential mediation of any association
by gestational age at birth and birthweight, and in
model 4 for potential mediation by BMI of the child
at the time of vascular assessment. We explored
whether there were any diﬀerences in associations by
sex of the child by testing for an interaction between sex
and the exposure (depressive symptoms or anxiety) in
model 2, using the Wald test. The equality of betas of a
psychosocial measure at two gestational time points, or
between mothers and fathers, was tested using the
Wald-statistic. Associations are also checked for linear-
ity using restricted cubic splines within ordinary least
squares linear regression analysis (OLS) in R (R
Foundation for Statistical Computing).
Results
Table 1 shows the characteristics of the mothers and
children included in this study. Table 2 shows the cor-
relations between the maternal depressive symptoms
and anxiety scores at all three time points and the
fathers’ equivalent measurements. There were strong
correlations between depressive symptoms and anxiety
at each time point in the mothers, and also in the
fathers. Over time, in the mothers, these measurements
correlated strongly with each other. There were weak
to modest correlations between maternal depressive
symptoms and anxiety and paternal equivalent
outcomes.
1100 European Journal of Preventive Cardiology 21(9)
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Study population (n¼4318)
Maternal
Age at delivery (years) 29.3 4.4 (26.3–32.3)
White ethnicity (yes) 98.7
Pre-pregnancy body mass index (kg/m
2) 22.8 3.6 (21.0–24.7)
Obesity (body mass index  30kg/m
2) (yes) 4.5
Social class
I (professional/managerial) 7.1
II 35.9
III (non-manual) 41.7
III (manual) 6.3
IV 7.6
V (unskilled manual workers) 1.4
Primiparous (yes) 49.4
Smoking
Non-smoking 77.3
Stopped before pregnancy or in first trimester 11.1
Smoked during pregnancy 11.6
Alcohol
None 43.7
<1 glass/week 41.0
>1 glass/week 13.7
>1 glass/day 1.5
Pregnancy-related hypertension (yes) 15.5
Maternal stress
Anxiety at gestational week 18 as a continuous score 5 3 (3–7)
Anxiety at gestational week 32 as a continuous score 5 3 (2–7)
Depressive symptoms at gestational week 18 as a continuous score 6 5 (3–9)
Depressive symptoms at gestational week 32 as a continuous score 6 5 (3–10)
Pre- and postnatal anxiety categories (n¼3375)
a
Low anxiety at all time points 59.9
Prenatal anxiety only 19.8
Postnatal anxiety only 5.8
High anxiety at all time points 14.5
Pre- and postnatal depressive symptom categories (n¼3421)
a
Low depressive symptoms at all time points 61.6
Prenatal depressive symptoms only 15.0
Postnatal depressive symptoms only 8.7
High depressive symptoms at all time points 14.6
Child at birth
Born through caesarean section (yes) 9.6
Sex (boys) 49.4
Gestational age (weeks) 39.6 1.6 (38.6–40.6)
Premature (<37 weeks) (yes) 3.7
Birthweight (g) 3456 494 (1366–5546)
(continued)
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action by sex and therefore all multivariable association
results are presented with both females and males com-
bined. Furthermore, there was no evidence for non-
linear associations: we therefore present results examin-
ing linear associations.
At both gestational ages, there was no strong evi-
dence that maternal depressive symptoms or anxiety
were associated with adverse cardiovascular function
in any of the multivariable models (Table 3).
Maternal depressive symptoms in pregnancy at both
time points were associated with larger brachial artery
Table 1. Continued
Study population (n¼4318)
Child at age 10 assessment
Age (years) 10.7 0.2 (10.5–10.8)
Height (cm) 144 7 (140–149)
Body mass index (kg/m
2) 18.1 3.0 (16.3–20.0)
Systolic blood pressure (mmHg) 104 9 (98–109)
Diastolic blood pressure (mmHg) 60 8 (54–65)
Flow-mediated dilatation (mm) (n¼3830) 0.21 0.08 (0.15–0.27)
Pulse wave velocity (m/s) (n¼4286) 7.55 1.22 (6.75–8.35)
Distensibility coefficient (% per mmHg) (n¼3943) 12.5 6.1 (9.0–16.0)
Brachial artery diameter (mm) (n¼3830) 2.67 0.30 (2.47–2.86)
Values are mean SD (IQR) or %;
aLow anxiety/depressive symptoms both pre- and postnatally: all scores for the
respective exposure (anxiety or depressive symptoms) lower than the 80th percentile. Prenatal anxiety/depressive
symptoms: one or both of the prenatal scores at or higher than the 80th percentile, but the postnatal score lower
than the 80th percentile. Postnatal anxiety/depressive symptoms: both prenatal scores lower than the 80th percentile and
the postnatal score at or higher than the 80th percentile. High anxiety/depressive symptoms: all scores at or higher than
the 80
th percentile. 80
th percentile scores: Anxiety: 7 at gestational week 18; 7 at gestational week 32; 6 at baby age 8
months. Depressive symptoms: 10; 11; 8 respectively.
Table 2. Correlation coefficients between maternal depressive symptoms and anxiety at gestational weeks 18 and 32, and at 8
months postnatally, and paternal depressive symptoms and anxiety at partner’s gestational week 19
18 weeks 32 weeks Postnatal Paternal
EPDS CCEI EPDS CCEI EPDS CCEI EPDS CCEI
EPDS depressive symptoms at week 18 1
n¼4318
CCEI anxiety at week 18 0.74 1
n¼4318 n¼4318
EPDS depressive symptoms at week 32 0.64 0.57 1
n¼4318 n¼4318 n¼4318
CCEI anxiety at week 32 0.60 0.67 0.76 1
n¼4318 n¼4318 n¼4318 n¼4318
EPDS depressive symptoms 8 months postnatal 0.50 0.46 0.54 0.50 1
n¼4173 n¼4173 n¼4173 n¼4173 n¼4173
CCEI anxiety 8 months postnatal 0.47 0.53 0.49 0.56 0.76 1
n¼4181 n¼4181 n¼4181 n¼4181 n¼4142 n¼4181
Paternal EPDS depressive symptoms 0.24 0.19 0.20 0.18 0.17 0.16 1
n¼3589 n¼3589 n¼3589 n¼3589 n¼3475 n¼3484 n¼3589
Paternal CCEI anxiety 0.15 0.14 0.13 0.11 0.12 0.12 0.68 1
n¼3576 n¼3576 n¼3576 n¼3576 n¼3463 n¼3473 n¼3545 n¼3576
All p-values are <0.001; CCEI, Crown–Crisp experiential index; EPDS, Edinburgh Postnatal Depression Scale.
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but with some evidence that these associations might be
mediated by birthweight/gestational age and oﬀspring
adiposity at the time of assessment of vascular function
(models 3 and 4). Depressive symptoms at 18 weeks
gestation were also associated with lower diastolic
blood pressure. Maternal anxiety at 18 weeks gestation
was also associated with brachial artery diameter
(model 2), again with some evidence of mediation by
birthweight/gestational age and oﬀspring adiposity.
Table 4 compares the multivariable associations of
maternal depressive symptoms with oﬀspring vascular
outcomes to the equivalent associations of paternal
symptoms. Paternal depressive symptoms or anxiety
were not associated with any of the vascular outcomes
in any models. For almost all associations, there was
statistical evidence that the paternal–oﬀspring associ-
ations were consistent with the maternal–oﬀspring
associations. There was some statistical evidence that
the inverse association of maternal stress with oﬀspring
DBP was diﬀerent to the paternal null association
(Wald-statistic p¼0.04).
Table 5 shows the multivariable associations of post-
natal maternal depressive symptoms and anxiety with
oﬀspring vascular function. Consistent with the ﬁnd-
ings of a lack of associations at each time point with
oﬀspring outcomes and of the strong correlations
between symptoms at each time point, maternal post-
natal symptoms were not strongly associated with over-
all adverse oﬀspring vascular outcomes. There was
some evidence that oﬀspring of mothers with postnatal
depressive symptoms or anxiety had a lower SBP and
DBP. These associations were not explained by gesta-
tional duration, birthweight, or oﬀspring age at vascu-
lar assessment.
Discussion
We have found no convincing evidence that prenatal
psychosocial stress, in the form of maternal depressive
symptoms or anxiety, causes adverse levels of oﬀspring
blood pressure, endothelial function, arterial stiﬀness,
brachial artery distensibility, or brachial diameter
assessed at age 10–11 years via intrauterine mechan-
isms. Indeed for most outcomes, there was no associ-
ation. Furthermore, the point estimates for the
maternal–oﬀspring association were very similar to
those for the paternal–oﬀspring associations, providing
further evidence against the hypothesis that exposure to
maternal stress in utero causes adverse developmental
eﬀects on vascular structure/function. Maternal depres-
sive symptoms and anxiety in the postnatal period were
associated with lower blood pressure in the oﬀspring
(i.e. in the opposite direction to what might be
expected), though the magnitudes of association were
small. As postnatal stress was not the prime focus of
this paper, this could be a chance ﬁnding and requires
further replication and detailed assessment to ascertain
whether this is robust.
Our main ﬁndings seem to be in line with the only
previous study of a somewhat similar association in a
general population cohort that we are aware of, in
which we did not ﬁnd an association between prenatal
maternal depressive symptoms and anxiety with oﬀ-
spring blood pressure in Dutch children at age 5–7.
21
However, that previous study did report an association
between the accumulation of multiple prenatal mater-
nal stressors and higher oﬀspring systolic and diastolic
blood pressure. In the current study, we do not have a
measure of the accumulation of multiple psychosocial
stressors available. It is possible that the accumulation
of diﬀerent stressors can exert a programming eﬀect on
the oﬀspring, which is not identiﬁed in a study such as
this that assesses just two sources of stress (depression/
anxiety) that are highly related to each other. Maternal
cortisol early in pregnancy appears to be associated
with both increased vascular resistance and lower arter-
ial elasticity in children aged 5–7.
32,33 Possibly, the
stressors in the current study are not causing suﬃcient
rises in maternal cortisol concentrations to exert eﬀects
on oﬀspring arterial parameters. Of note the evidence
for a direct association between psychosocial stress and
cortisol, and thus the role of cortisol in fetal program-
ming via psychosocial stress, has been a main point of
discussion in a recent review by Glover et al.
6
Nonetheless our results are important as they strongly
suggest that levels of maternal stress in pregnancy that
are experienced by a relatively large proportion of preg-
nant women are unlikely to adversely aﬀect their oﬀ-
spring’s vascular health.
It is possible that there are speciﬁc sensitive periods
in which maternal stress has an eﬀect on future cardio-
vascular function.
34 However, the clear lack of associ-
ations at either 18 weeks or 32 weeks and the
correlation between symptoms across these two time
points and with the postnatal measurement (suggesting
women would be ranked similarly throughout preg-
nancy) argues against this as an explanation for our
null results.
The associations of maternal symptoms with wider
brachial diameter and lower diastolic blood pressure
were in the opposite direction to what we hypothesized
and require further replication before one could con-
sider these are not due to chance.
The large sample size is a strength of the current
study, but as in most cohort studies, selective loss to
follow up was present. Those who have remained in the
cohort tend to be of higher socioeconomic position
24,25
and we have shown that those who were included in the
analyses here had lower parental depressive and anxiety
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 at University College London on June 26, 2015 cpr.sagepub.com Downloaded from scores than those who were excluded because of missing
outcome or covariable data (see supplementary table,
available online). If the association of parental symp-
toms with oﬀspring outcomes was strong and inverse in
those lost to follow up, then we may have biased null
ﬁndings due to selection bias, but in separate studies
exploring selection bias due to loss to follow up/missing
data any bias tends to be small
35,36 and we doubt this
would be suﬃcient to produce important associations
here.
Whilst the parental symptoms that we have assessed
here use validated tools, they are not the same as clin-
ical diagnoses and we cannot make any conclusions
about the eﬀects of more severe clinical depression or
anxiety in terms of its association with oﬀspring vascu-
lar function.
In conclusion, our ﬁndings suggest that maternal
prenatal psychosocial stress does not cause adverse oﬀ-
spring vascular function in 10–11 year old children via
intrauterine mechanisms. These results do not exclude
the possibility that severe prenatal clinical depression or
anxiety cause adverse oﬀspring vascular function via
intrauterine mechanisms, but to date we are not
aware of any study that has explored that possibility
in humans.
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